Tumor cell immune synapse interface (IS)

The tumor cell immune synapse interface is a specialized, highly organized physical contact area formed between an immune cell, such as a T cell or Natural Killer (NK) cell, and a target tumor cell. This interface, often referred to as the immunological synapse, is essential for the precise delivery of cytotoxic granules and the transmission of activation or inhibition signals (Dustin, 2014, Nature Reviews Immunology). It is structured into supramolecular activation clusters (SMACs) where receptors like the T-cell receptor (TCR) and major histocompatibility complex (MHC) molecules concentrate to initiate immune responses (Chen & Mellman, 2013, Nature). In many cancers, the integrity or function of this interface is compromised by the expression of inhibitory checkpoint molecules like PD-L1, which bind to PD-1 on T cells to induce exhaustion and immune evasion (Grakoui et al., 1999, Science). Therapeutic interventions often target specific components within this interface, such as using monoclonal antibodies to block inhibitory pathways or bispecific T-cell engagers (BiTEs) to artificially bridge the synapse (Dieckmann et al., 2016, Frontiers in Oncology). Understanding the dynamics of this interface is crucial for developing next-generation immunotherapies, including CAR-T cells and checkpoint modulators, which aim to restore effective immune surveillance and tumor eradication (Vargas et al., 2014, Cancer Immunology Research).

Other names

Immunological synapseT-cell-tumor synapseSupramolecular activation clusterSMAC

Modulation of immune checkpoint signaling and stabilization of the physical contact between immune effector cells and tumor cells to facilitate cytolytic activity.